Evidence map›Paper›PMID 22683041›Full record

Trial reportThe American journal of cardiology2012

Usefulness of Doppler echocardiographic left ventricular diastolic function and peak exercise oxygen consumption to predict cardiovascular outcomes in patients with systolic heart failure (from HF-ACTION).

Julius M Gardin, Eric S Leifer, Dalane W Kitzman, Gerald Cohen, Joel S Landzberg, William Cotts, Eugene E Wolfel, Robert E Safford, Renee L Bess, Jerome L Fleg

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The American journal of cardiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Julius M GardinSt. John Hospital and Medical Center, Detroit, MI, USA. jgardin@hackensackumc.org
Eric S Leifer
Dalane W Kitzman
Gerald Cohen
Joel S Landzberg
William Cotts
Eugene E Wolfel
Robert E Safford
Renee L Bess
Jerome L Fleg
St. John Hospital & Medical Center · USNational Heart Lung and Blood Institute · USHackensack University Medical Center · USNorthwestern University · USUniversity of Colorado Health · USWake Forest University · USWinnMed · US

Funding

ACTION - A CHF Trial Investigating Outcomes of ExerciseU01HL063747 · NHLBI · DUKE UNIVERSITY · PI O'CONNOR, CHRISTOPHER M · 2002 to 2008
$24.8M
ACTION EQOL STUDYU01HL066461 · NHLBI · DUKE UNIVERSITY · PI SCHULMAN, KEVIN ALAN · 2002 to 2008
$2.7M
ACTION - A CHF Trial Investigating Outcomes of ExerciseU01HL064250 · NHLBI · HENRY FORD HEALTH SYSTEM · PI KETEYIAN, STEVEN J · 2002 to 2007
$1.4M
CHF TRIAL INVESTIGATING OUTCOMES OF EXERCISE TRAININGU01HL066491 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KITZMAN, DALANE W · 2002 to 2007
$1.4M
ACTION - A CHF Trial Investigating Outcomes of ExerciseU01HL064264 · NHLBI · WASHINGTON UNIVERSITY · PI EWALD, GREGORY A · 2002 to 2006
$1.0M
ACTION - A CHF Trial Investigating Outcomes of ExerciseU01HL068973 · NHLBI · BOSTON MEDICAL CENTER · PI COLUCCI, WILSON S. · 2002 to 2007
$1.0M
ACTION - A CHF Trial Investigating Outcomes of ExerciseU01HL066501 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI PINA, ILEANA L · 2002 to 2007
$973k
ACTION - A CHF Trial Investigating Outcomes of ExerciseU01HL066497 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BITTNER, VERA A · 2002 to 2005
$838k
ACTION - A CHF Trial Investigating Outcomes of ExerciseU01HL064257 · NHLBI · OREGON HEALTH AND SCIENCE UNIVERSITY · PI ALHARETHI, RAMI · 2002 to 2005
$773k
ACTION-A CHF TRIAL INVESTIGATING OUTCOMES OF EXERCISEU01HL066494 · NHLBI · OHIO STATE UNIVERSITY · PI ABRAHAM, WILLIAM TOBER · 2002 to 2005
$766k
ACTION - A CHF Trial Investigating Outcomes of ExerciseU01HL068980 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FONAROW, GREGG C · 2002 to 2006
$709k
ACTION - A CHF Trial Investigating Outcomes of ExerciseU01HL066482 · NHLBI · EMORY UNIVERSITY · PI SMITH, ANDREW · 2002 to 2005
$643k
NHLBI NIH HHS U01 HL063747NHLBI NIH HHS U01 HL064250NHLBI NIH HHS U01 HL064257NHLBI NIH HHS U01 HL064264NHLBI NIH HHS U01 HL064265NHLBI NIH HHS U01 HL066461NHLBI NIH HHS U01 HL066482NHLBI NIH HHS U01 HL066491NHLBI NIH HHS U01 HL066494NHLBI NIH HHS U01 HL066497NHLBI NIH HHS U01 HL066501NHLBI NIH HHS U01 HL068973NHLBI NIH HHS U01 HL068980
6 · The paper itself

Abstract

Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) was a multicenter, randomized controlled trial designed to examine the safety and efficacy of aerobic exercise training versus usual care in 2,331 patients with systolic heart failure (HF). In HF-ACTION patients with rest transthoracic echocardiographic measurements, the predictive value of 8 Doppler echocardiographic measurements-left ventricular (LV) diastolic dimension, mass, systolic (ejection fraction) and diastolic (mitral valve peak early diastolic/peak late diastolic [E/A] ratio, peak mitral valve early diastolic velocity/tissue Doppler peak early diastolic myocardial velocity [E/E'] ratio, and deceleration time) function, left atrial dimension, and mitral regurgitation severity-was examined for a primary end point of all-cause death or hospitalization and a secondary end point of cardiovascular disease death or HF hospitalization. Also compared was the prognostic value of echocardiographic variables versus peak oxygen consumption (Vo(2)). Mitral valve E/A and E/E' ratios were more powerful independent predictors of clinical end points than the LV ejection fraction but less powerful than peak Vo(2). In multivariate analyses for predicting the primary end point, adding E/A ratio to a basic demographic and clinical model increased the C-index from 0.61 to 0.62, compared with 0.64 after adding peak Vo(2). For the secondary end point, 6 echocardiographic variables, but not the LV ejection fraction or left atrial dimension, provided independent predictive power over the basic model. The addition of E/E' or E/A to the basic model increased the C-index from 0.70 to 0.72 and 0.73, respectively (all p values <0.0001). Simultaneously adding E/A ratio and peak Vo(2) to the basic model increased the C-index to 0.75 (p <0.0005). No echocardiographic variable was significantly related to the change from baseline to 3 months in exercise peak Vo(2). In conclusion, the addition of echocardiographic LV diastolic function variables improves the prognostic value of a basic demographic and clinical model for cardiovascular disease outcomes.

Indexed as

Echocardiography, DopplerOxygen ConsumptionAgedExerciseExercise TestFemaleHeart Failure, SystolicHumansMaleMiddle AgedPrognosisVentricular Function, Left

Identifiers

PMID22683041
PMCPMC3432165
OpenAlexW1988477789

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.